1. Home
  2. JJSF vs AUPH Comparison

JJSF vs AUPH Comparison

Compare JJSF & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JJSF
  • AUPH
  • Stock Information
  • Founded
  • JJSF 1971
  • AUPH 1993
  • Country
  • JJSF United States
  • AUPH Canada
  • Employees
  • JJSF N/A
  • AUPH N/A
  • Industry
  • JJSF Specialty Foods
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • JJSF Consumer Staples
  • AUPH Health Care
  • Exchange
  • JJSF Nasdaq
  • AUPH Nasdaq
  • Market Cap
  • JJSF 1.7B
  • AUPH 1.6B
  • IPO Year
  • JJSF N/A
  • AUPH 1999
  • Fundamental
  • Price
  • JJSF $85.69
  • AUPH $14.50
  • Analyst Decision
  • JJSF Buy
  • AUPH Strong Buy
  • Analyst Count
  • JJSF 2
  • AUPH 2
  • Target Price
  • JJSF $142.50
  • AUPH $13.00
  • AVG Volume (30 Days)
  • JJSF 188.5K
  • AUPH 1.3M
  • Earning Date
  • JJSF 11-17-2025
  • AUPH 11-04-2025
  • Dividend Yield
  • JJSF 3.78%
  • AUPH N/A
  • EPS Growth
  • JJSF N/A
  • AUPH N/A
  • EPS
  • JJSF 4.29
  • AUPH 0.42
  • Revenue
  • JJSF $1,599,746,000.00
  • AUPH $260,111,000.00
  • Revenue This Year
  • JJSF $3.00
  • AUPH $17.33
  • Revenue Next Year
  • JJSF $2.90
  • AUPH $14.31
  • P/E Ratio
  • JJSF $19.74
  • AUPH $31.33
  • Revenue Growth
  • JJSF 0.49
  • AUPH 25.59
  • 52 Week Low
  • JJSF $82.75
  • AUPH $6.55
  • 52 Week High
  • JJSF $180.80
  • AUPH $13.54
  • Technical
  • Relative Strength Index (RSI)
  • JJSF 27.12
  • AUPH 75.43
  • Support Level
  • JJSF $83.17
  • AUPH $11.96
  • Resistance Level
  • JJSF $91.29
  • AUPH $12.70
  • Average True Range (ATR)
  • JJSF 2.19
  • AUPH 0.64
  • MACD
  • JJSF -0.32
  • AUPH 0.27
  • Stochastic Oscillator
  • JJSF 22.39
  • AUPH 66.61

About JJSF J & J Snack Foods Corp.

J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: